Facility Evaluation Report

Licensing Program Analyst (LPA) Fernandes-Goes arrived unannounced with the purpose of closing a complaint investigation. During subsequent complaint investigation Department learned there are related deficiencies observed during the visit. LPA met with Catherine Scott - Administrator. Following item were observed during investigation visits:

Department observed during resident’s R4 file review and staff S2 interview on 8/17/2022 that resident R4’s physician assessment dated 7/15/2022 has a diagnostic of Type 2 diabetes; resident came back from SKNF with order for Humalog 100 units 3x a day and glucose testing needed; resident R4 physician’s assessment states that R4 can’t manage his medication including injections and glucose testing; on 7/21/2022 facility faxed doctor stating “ Resident back from SNF insulin VIAL order sliding scale,” and requesting a new order for Lispro inulin – “Insulin pen need to be available in order for Medication Technician to coach resident on getting it once nurse is not available during weekend.” According to records reviewed Lisopro filled 8/2/2022 and for the month of August 2022 resident R4 has self-administer its own injection and glucose test from 8/1/2022 to 8/16/2022. (see copy of documentation, LIC 811 confidential name list, LIC 809-D) Per Title 22 Regulations #87628 Diabetes “ The licensee shall be permitted to accept or retain a resident who has diabetes if the resident is able to perform his/her own glucose testing with blood or urine specimens, and is able to administer his/her own medication including medication administered orally or through injection, or has it administered by an appropriately skilled professional.” (Continued LIC 809-C)